TiumBio Co., Ltd. (KOSDAQ: 321550)
South Korea
· Delayed Price · Currency is KRW 4,925.00
-115.00 (-2.28%)
Nov 15, 2024, 9:00 AM KST
TiumBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 7,910 | 4,899 | 9,118 | 56.8 | 1,049 | 1,113 |
| Revenue Growth (YoY) | -21.93% | -46.27% | 15952.75% | -94.59% | -5.75% | - |
| Gross Profit | 7,910 | 4,899 | 9,118 | 56.8 | 1,049 | 1,113 |
| Selling, General & Admin | 12,740 | 11,610 | 9,999 | 5,008 | 3,504 | 2,440 |
| Research & Development | 11,700 | 17,867 | 21,287 | 25,801 | 9,830 | 5,858 |
| Operating Expenses | 27,865 | 32,731 | 34,758 | 32,753 | 14,352 | 9,133 |
| Operating Income | -19,956 | -27,832 | -25,640 | -32,696 | -13,303 | -8,020 |
| Interest Expense | -3,957 | -2,471 | -808.36 | -518.46 | -40.85 | -19.62 |
| Interest & Investment Income | 943.74 | 1,225 | 1,305 | 919.34 | 1,215 | 965.27 |
| Earnings From Equity Investments | -1,079 | -1,257 | -1,303 | -385.86 | - | - |
| Currency Exchange Gain (Loss) | 235.21 | 127.42 | 65.61 | -11.63 | -99.27 | -24.55 |
| Other Non Operating Income (Expenses) | -2,520 | -2,337 | -3,991 | 612.57 | 17.54 | 7.26 |
| EBT Excluding Unusual Items | -26,333 | -32,544 | -30,372 | -32,080 | -12,211 | -7,091 |
| Gain (Loss) on Sale of Investments | -4,627 | 1,728 | -1,037 | -172.6 | 93.07 | - |
| Gain (Loss) on Sale of Assets | -16.03 | -13.27 | 6.28 | -0 | -0.45 | -0.13 |
| Other Unusual Items | 13,314 | 11,792 | - | - | - | - |
| Pretax Income | -17,662 | -19,038 | -31,402 | -32,253 | -12,119 | -7,091 |
| Earnings From Continuing Operations | -17,662 | -19,038 | -31,402 | -32,253 | -12,119 | -7,091 |
| Minority Interest in Earnings | 1,726 | 1,127 | 1,550 | 615.61 | - | - |
| Net Income | -15,936 | -17,911 | -29,853 | -31,637 | -12,119 | -7,091 |
| Net Income to Common | -15,936 | -17,911 | -29,853 | -31,637 | -12,119 | -7,091 |
| Shares Outstanding (Basic) | 25 | 24 | 24 | 24 | 23 | 20 |
| Shares Outstanding (Diluted) | 25 | 24 | 24 | 24 | 23 | 20 |
| Shares Change (YoY) | 3.90% | 1.79% | 0.63% | 1.39% | 17.20% | - |
| EPS (Basic) | -635.40 | -734.27 | -1245.75 | -1328.50 | -515.97 | -353.85 |
| EPS (Diluted) | -635.40 | -734.27 | -1246.00 | -1329.00 | -516.00 | -354.00 |
| Free Cash Flow | -34,860 | -38,952 | -27,198 | -36,647 | -10,246 | -4,954 |
| Free Cash Flow Per Share | -1389.92 | -1596.88 | -1134.99 | -1538.88 | -436.25 | -247.19 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -252.30% | -568.14% | -281.22% | -57566.15% | -1268.26% | -720.54% |
| Profit Margin | -201.48% | -365.62% | -327.42% | -55701.69% | -1155.33% | -637.15% |
| Free Cash Flow Margin | -440.73% | -795.14% | -298.31% | -64522.48% | -976.81% | -445.10% |
| EBITDA | -16,531 | -24,578 | -22,169 | -30,753 | -12,285 | -7,185 |
| EBITDA Margin | -209.00% | - | -243.14% | - | - | - |
| D&A For EBITDA | 3,425 | 3,254 | 3,472 | 1,944 | 1,018 | 834.31 |
| EBIT | -19,956 | -27,832 | -25,640 | -32,696 | -13,303 | -8,020 |
| EBIT Margin | -252.30% | - | -281.22% | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.